Advancing the repurposing of ivermectin for malaria

Chaccour, C.J. (Carlos J.); Rabinovich, N.R. (N. Regina)

Registro completo de metadatos

Aparece en las colecciones:

DA - Instituto de Salud Tropical - Artículos de revista

Campo DC	Valor	Lengua/Idioma
dc.creator	Chaccour, C.J. (Carlos J.)	-
dc.creator	Rabinovich, N.R. (N. Regina)	-
dc.date.accessioned	2021-11-16T08:38:29Z	-
dc.date.available	2021-11-16T08:38:29Z	-
dc.date.issued	2019	-
dc.identifier.citation	Chaccour, C.J. (Carlos J.); Rabinovich, N.R. (N. Regina). "Advancing the repurposing of ivermectin for malaria". The Lancet. 393 (10180), 2019, 1480 - 1481	es_ES
dc.identifier.issn	0140-6736	-
dc.identifier.uri	https://hdl.handle.net/10171/62577	-
dc.description.abstract	Ivermectin lays the path for a whole new concept: drug-based vector control. Ivermectin, or indeed any effective endectocide, could be administered to eligible members of the at-risk community as a complementary tool for vector control. It could be administered alone or in combination with partner drugs to allow for integrated management of malaria or neglected tropical diseases, directly responding to residual transmission by targeting malaria and some lymphatic filariasis vectors, regardless of their feeding behaviour.	es_ES
dc.language.iso	eng	es_ES
dc.publisher	Elsevier BV	es_ES
dc.rights	info:eu-repo/semantics/openAccess	es_ES
dc.subject	Ivermectin	es_ES
dc.subject	Malaria	es_ES
dc.subject	Endectocide	es_ES
dc.subject	Tropical diseases	es_ES
dc.title	Advancing the repurposing of ivermectin for malaria	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.description.note	This is an Open Access article under the CC BY-NC-ND 4.0 license.	es_ES
dc.identifier.doi	10.1016/S0140-6736(18)32613-8	-
dadun.citation.endingPage	1481	es_ES
dadun.citation.number	10180	es_ES
dadun.citation.publicationName	The Lancet	es_ES
dadun.citation.startingPage	1480	es_ES
dadun.citation.volume	393	es_ES